Regenexx-ACL Procedure Featured in Outside Magazine

By /

Regenexx-ACL procedure

The Regenexx-ACL Procedure, our groundbreaking  treatment for knee ACL tears using precise injections of the patient’s own stem cells was just featured in Outside Magazine. It’s a well-balanced piece of journalism for a new technology. As you may have guessed, Orthopedic surgeons are quite skeptical that they may have to give up 70-80% of ACL surgeries to a precise guided injection of stem cells. However, that’s why we just submitted an imaging analysis research paper and are recruiting right now for an ACL study in which we’re offering free care to those patients who agree to be randomized.

To review, our knee ACL procedure is best for those patients with ACL tears that are less than 1 cm retracted (the ends pulled somewhat apart). We also see quite a few patients whose ACLs are not retracted back, but are just severely stretched throughout. I saw one of these patients yesterday. His ACL fibers were just “exploded in place”, meaning they were all still intact, but had gone from a normal parallel appearance to a wavy mess of a ligament that was enlarged. His ligament looked very similar to this ACL we treated with stem cells. We also treat many patients with partial tears. Most patients can get back to sports quicker than if they had an ACL surgery, but some of the more severe ligament tears have similar healing times. The big difference is ending up with a ligament that we believe is much more like the original equipment, rather than an artificial ACL ligament which is too steep. The other advantage is the ability to also inject and treat the newly discovered ALL ligament, which helps the ACL control the knee in rotation. No surgery right now is addressing this ligament.

As I’ve always said, at Regenexx we’re not just playing with magic stem cells, but creating a new medical specialty-Interventional Orthopedics. Thanks to Outside for recognizing that we have a disruptive technology in our ACL treatment, one that we believe, once adopted by many physicians, will starkly reduce ACL surgery rates.

Learn about Regenexx procedures for ACL conditions.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Regenexx-ACL
Copyright © Regenexx 2021. All rights reserved.



9035 Wadsworth Pkwy #1000
Westminster, CO 80021


*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.